THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $98,000 | -66.8% | 10,300 | -74.1% | 0.00% | – |
| Q3 2021 | $295,000 | +46.0% | 39,700 | +305.1% | 0.00% | – |
| Q1 2021 | $202,000 | -63.8% | 9,800 | -54.6% | 0.00% | -100.0% |
| Q4 2019 | $558,000 | +174.9% | 21,600 | +74.1% | 0.00% | +100.0% |
| Q2 2019 | $203,000 | -46.3% | 12,409 | -20.5% | 0.00% | 0.0% |
| Q2 2018 | $378,000 | 0.0% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $378,000 | -0.3% | 15,600 | +14.7% | 0.00% | 0.0% |
| Q4 2017 | $379,000 | -16.2% | 13,600 | +3.0% | 0.00% | -50.0% |
| Q3 2017 | $452,000 | +97.4% | 13,200 | +109.5% | 0.00% | +100.0% |
| Q1 2017 | $229,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |